Opinion
2012-1693
10-09-2012
JANSSEN PHARMACEUTICALS, INC. AND JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, LLC, Plaintiffs-Appellees, v. WATSON LABORATORIES, INC. AND SANDOZ, INC., Defendants, AND LUPIN PHARMACEUTICALS, INC. AND LUPIN LTD., Defendants-Appellants.
NOTE: This order is nonprecedential.
Appeal from the United States District Court for the District of New Jersey in consolidated case no. 08-CV-5103, Judge Stanley R. Chesler.
ON MOTION
ORDER
Lupin Pharmaceuticals, Inc. et al. (Lupin) moves to expedite the appeal, briefing, and oral argument. Lupin states that Janssen Pharmaceuticals, Inc. et al. (Janssen) oppose.
Upon consideration thereof,
IT IS ORDERED THAT:
The motions are granted to the following extent: Lupin's opening brief is due no later than October 26, 2012; Janssen's brief is due no later than November 30, 2012; Lupin's reply brief and the joint appendix are due no later than December 10, 2012. No extensions of time should be anticipated. Oral argument will be scheduled by subsequent order.
FOR THE COURT
_________________
Jan Horbaly
Clerk
s8